Preparation and in Vitro Evaluation of Montelukast Sodium Oral Nanoemulsion

Abstract

Objective: Oral nanoemulsion (NE) represent one of the newest technology to enhance intestinal drug permeability, bioavailability and facilitate swallowing of the oral dosage form.Methods: In this study, montelukast sodium (MS) nanoemulsions (NEs) were formulated by ultra-sonication using different surfactants (tween 20, tween 60 and tween 80) in different surfactant: co-surfactant (ethanol) ratios (Smix). The prepared NEs were evaluated for different parameters including droplet size (DS) using zetasizer as a function of ultra-sonication time, dispersibility, phase separation, conductivity, percent transmittance, optical transparency, in vitro release in addition to morphology using transmission electron microscopic (TEM).Results: The results revealed that F3 was the optimum formula having an average DS 32.95±2.8 nm after 5 min ultra-sonication assured by zetasizer and TEM, furthermore, a clear to bluish NE was formed after aqueous dilution with high conductivity (59.2±1.76 μs/cm) which indicated the formation of O/W NE. In addition, an optically clear NE was formed with (88.6±2.1) % transmittance with no sedimentation, creaming or separation after centrifugation signifying the formation of a stable NE. Finally, F3 showed faster dissolution rate (92.45%±1.66) after 30 min compared to other formulas.Conclusion: The net result of this study is the formulation of a stable oral NE containing MS which presents new easily swallowed dosage form that may enhance drug permeability as well as it may reduce drug metabolism leading to improving bioavailability for asthmatic patients.

In Vivo Characterization of Less Painful Propofol Nanoemulsion Using Palm Oil for Intravenous Drug Delivery

“…Nanoemulsion are one of the dosage form that develop not only for oral route [25,26], topical usage [27] but also populer for parenteral usage like propofol nanoemulsion. Propofol is one of the anesthetic drug that common usage in the hospital but the pain problem make this drug become not comfortable to use.…”

A Review on Nanoemulsions: Formulation, Composition, and Applications

“…Yasser et al formulated NE of montelukast sodium where the mean droplet size ranged from about 65 to 85 nm and drug release from this formulation was found to be 93% after a period of 30 min [68].…”

“…The blending of oils and emulsifiers improved the absorption of two phytochemicals that are now utilized in treating two major chronic inflammatory diseases which are periodontitis [68] and bowel disease (Crohn's disease and ulcerative colitis) [69]. Periodontitis is a longterm inflammatory disease that attacks the supporting structures of the teeth with many factors such as microbial, genetic, environmental, and host factor play a role in the beginning of that condition.…”

Optimization and in Vitro Evaluation of the Release of Class Ii Drug From Its Nanocubosomal Dispersion

“…The results indicated that all the prepared nanocubosomal dispersion formulas were o/w type since high conductivity (76-252μs/cm). The higher conductivity is due to a large percentage of water, which allows higher freedom for mobility of ions [26].…”